THE NEED FOR SPEED

EpiVax Therapeutics developed a game-changing neoantigen personalized cancer vaccine proprietary process with an accelerated biopsy-to-needle timeline of under 4 weeks 

 

Subscribe Form

  • LinkedIn

©2020 by EpiVax Therapeutics, Inc.